Wins Diagnostics Provider of the Year for the third time, alongside Facilities and ICT accolades
In a world where quality healthcare and fast, accurate diagnostics are more critical than ever, one company is redefining how patients in the Philippines access medical services. At this year’s Healthcare Asia Awards 2025 held in Kuala Lumpur, Singapore Diagnostics (SGD) emerged as one of the most celebrated names in the region. The Philippine-based medical laboratory earned three major honors, including Diagnostics Provider of the Year, a recognition it has now claimed for three consecutive years.
These accolades not only affirm SGD’s leadership in laboratory diagnostics but also spotlight its bold initiatives that combine innovation, digital transformation, and patient-first service delivery. The awards for Facilities Improvement Initiative of the Year and ICT Initiative of the Year further underscore the company’s commitment to raising the standards of diagnostics and bringing quality healthcare closer to every Filipino.
Established in 2013, SGD has grown into a nationwide network of over 60 locations, serving more than two million patients annually—up from 800,000 before the pandemic. As the local arm of Singapore-based Pathology Asia Holdings, SGD is among the few in the country accredited by the College of American Pathologists (CAP), a testament to its adherence to global quality benchmarks.
But what truly sets SGD apart is its drive to make healthcare more accessible. One of its most impactful offerings is the SGD Home Service Laboratory, a mobile phlebotomy solution that allows patients to schedule blood extractions from the comfort of their homes. By removing the need for clinic or hospital visits, the service eases the burden for patients with mobility issues, chronic conditions, or simply tight schedules.
SGD is also transforming how healthcare professionals are trained through its internal Credentialing Program. Last year alone, hundreds of its medical technologists completed specialized modules in fields like hematology, immunochemistry, and microbiology. This investment in people ensures that patients benefit not only from modern equipment but also from highly trained professionals using it.
Equally transformative is SGD’s digital infrastructure. Its Electronic Single Laboratory Integration Platform (e-SLIP) allows laboratories to communicate seamlessly, streamlining diagnostic workflows and minimizing errors. This platform has become a game-changer in a system where delays and miscommunications can directly impact patient care. With this, SGD now serves as the send-out partner for more than 800 laboratories across the Philippines, cementing its role as a vital part of the country’s healthcare ecosystem.
The company’s influence also extends beyond its own facilities. In 2024, SGD took over the laboratory operations of VisayasMed in Cebu, formerly known as Visayas Community Medical Center. By modernizing equipment, retraining staff, and optimizing diagnostic procedures, SGD helped the hospital dramatically cut down test result turnaround times and boost both patient outcomes and operational efficiency.
As healthcare continues to evolve in the digital age, SGD is not just keeping up—it’s leading the charge. With its patient-centric innovations, digital platforms, and ongoing expansion, the company is showing what’s possible when technology and compassion work hand in hand.
These recent wins at the Healthcare Asia Awards serve not just as trophies on a shelf, but as milestones on SGD’s mission to make high-quality healthcare more affordable, more accessible, and more human for millions of Filipinos.
To learn more about their services and initiatives, visit www.singaporediagnostics.com.
